Hester Biosciences Share Price

Hester Bios

CMP as on 02-Dec-20 9:46

₹ 1,774.00
-6.85 -0.38%

Open

₹ 1,775.05

Turnover (lac)

₹ 8

Prev. Close

₹ 1,780.85

Day's Vol (shares)

₹ 451

Day's Range (₹)

₹ 1,761.30
₹ 1,777.95

CMP as on01-Dec-20 15:18

₹ 1,790.00
-3.9 -0.22%

Open

₹ 1,762.00

Turnover (lac)

₹ 347

Prev. Close

₹ 1,793.90

Day's Vol (shares)

₹ 280

Day's Range

₹ 1,762.00
₹ 1,800.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 23-Oct-2020 - -
HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2020 ,inter alia, to consider and approve This is to inform you that as per Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended time to time), a Meeting of the Board of Directors of the Company will be held on Saturday, 31.10.2020 at 10:30 a.m. at its Factory Office situated at Village Merda-Adraj, Taluka Kadi, District Mehsana, Gujarat, to consider the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended on 30.09.2020. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended on 30.09.2020. (As Per BSE Announcement dated on 31.10.2020)
Board Meeting - 25-Jul-2020 - -
HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2020 ,inter alia, to consider and approve Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30.06.2020. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30.06.2020. The Board Meeting commenced at 10:30 a.m. and concluded at 11:15 a.m. You are requested to take the above information on your record. (As per BSE Announcement Dated on 30/07/2020)
Board Meeting - 15-Jun-2020 - -
Hester Biosciences Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on June 26, 2020, to consider the Standalone and Consolidated Audited Financial Results for the quarter and year ended on March 31, 2020 and to consider declaration of dividend, if any, on the equity shares of the Company, for the financial year 2019-20. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the followings: 1) Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31.03.2020. 2) Recommended dividend of 66% that is INR 6.60 per equity share of INR 10 each for the financial year 2019-20, subject to approval of members in the ensuing Annual General Meeting. 3) Appointment of Chadulal M. Shah & Co., Chartered Accountants, Ahmedabad, as a Statutory Auditor of the Company for first term of 3 years to hold office until 36th Annual General Meeting of the Company, subject to approval of members in the ensuing Annual General Meeting. The Board Meeting commenced at 10:30 a.m. and concluded at 12.30 p.m. You are requested to take the above information on your record. (As Per BSE Announcement Dated on 26.06.2020)
Board Meeting - 25-Apr-2020 - -
HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2020 ,inter alia, to consider and approve This is to inform you that as per Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended time to time), a Meeting of the Board of Directors of the Company will be held on Wednesday, 29 April 2020 at 9.30 a.m. to inter alia, consider and approve the change of Chief Financial Officer (Key Managerial Personnel) of the Company. We request you to take note of the above. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, have approved business as mentioned into Outcome of Board Meeting. (As Per BSE Announcement Dated on 29.04.2020) Board have approved the followings: 1. Approved the Resignation of Mr. Sahil Shah from the post of Chief Financial Officer (KMP) of the Company with effect from 29 April 2020. 2. Approved the Appointment of Mr. Chetas Patel as a Chief Financial Officer (KMP) of the Company with effect from 29 April 2020. 3. The board endorses the companys plan to work on the development of human vaccines, beginning with work on COVID-19 disease vaccine. (As Per BSE Bulletin Dated on 29.04.2020)
Board Meeting - 31-Mar-2020 - -
Outcome of Resolution passed by the Board of Directors by Circulation
Board Meeting - 29-Feb-2020 - -
HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/03/2020 ,inter alia, to consider and approve This is to inform you that as per Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended time to time), a Meeting of the Board of Directors of the Company will be held on Wednesday, 4 March 2020 at 10.30 a.m. at its Registered Office at 1st Floor, Pushpak, Panchvati Circle, Motilal Hirabhai Road, Ahmedabad 380006, to inter alia, consider and approve the appointment of Chief Financial Officer (CFO) and revision in list of Key Managerial Personnel (KMPs) of the Company. We request you to take note of the same. This is in reference to our letter dated 29 February 2020 intimating the date of the Board Meeting for consideration of Appointment of Chief Financial Officer (CFO) of the Company. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the Appointment of Mr. Sahil Shah as a Chief Financial Officer (KMP) the Company with effect from 1 March 2020. We have attached herewith Press Release issued in this regard. You are requested to take the above information on your record. In pursuance to Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Policy on Determination of Materiality, we hereby inform that the Board of Directors of the Company in its meeting held on 4 March 2020 has approved Changes in authorised Key Managerial Personnel of the Company due to appointment of Mr. Sahil Shah as a Chief Financial Officer (KMP) of the Company. (As Per BSE Announcement Dated on 04.03.2020)
Board Meeting - 27-Jan-2020 - -
HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2020 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended on 31 December 2019. Outcome of Board Meeting held today and Submission of Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended on 31 December 2019 (As Per BSE Announcement Dated on 07.02.2020)
Board Meeting - 13-Dec-2019 - -
HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/12/2019 ,inter alia, to consider and approve This is to inform you that as per Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended time to time), a Meeting of the Board of Directors of the Company will be held on Wednesday, 18 December 2019 at 10.30 a.m. at its Registered Office at 1st Floor, Pushpak, Panchvati Circle, Motilal Hirabhai Road, Ahmedabad 380006, to consider and approve the proposal of raising of funds by way of issue of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment, subject to the receipt of necessary approvals, in terms of the provisions of the SEBI Regulations and the Companies Act, 2013, as amended from time to time and other applicable laws and other businesses, if any. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the followings: 1) Issuance of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment for an amount not exceeding INR 150 crores, subject to approval of members through Postal Ballot process 2) Re-appointment of Mr. Rajiv Gandhi, CEO & Managing Director of the Company for the period of 3 years from 1 April 2020 to 31 March 2023, subject to approval of Members through Postal Ballot process. (As Per BSE Announcement dated on 18/12/2019)